Notes - Significant Accounting Policies For Preparation Of Consolidated Financial Statements

BrightPath Biotherapeutics Co., Ltd. - Filing #7580409

Concept As at
2018-03-31
2017-04-01 to
2018-03-31
Notes - Significant accounting policies for preparation of consolidated financial statements
Notes - Significant accounting policies for preparation of consolidated financial statements
Disclosure of scope of consolidation
Number of consolidated subsidiaries and names of major consolidated subsidiaries
(1) 連結子会社の数

1社

連結子会社の名称

株式会社アドバンスト・イミュノセラピー

 

Number of consolidated subsidiaries
1 xbrli:pure
Disclosure about fiscal years, etc. of consolidated subsidiaries

2.連結子会社の事業年度等に関する事項

連結子会社の株式会社アドバンスト・イミュノセラピーの決算日は12月31日ですが、連結決算日での仮決算を行った財務諸表を使用して、連結決算を行っております。

 

Talk to a Data Expert

Have a question? We'll get back to you promptly.